SUMMARY Of the first 128 patients to receive either heart or heart and lung transplants at Papworth Hospital, four developed Toxoplasma gondii infections acquired from the donor heart and two died. Six patients had passively acquired T gondii antibody as a result of blood transfusions around the time of transplantation. Eight patients developed antibodies against Tgondii, which were detectable by changes in the latex agglutination test titres but not by those of the dye test. These false positive latex agglutination reactions occurred simultaneously with cytomegalovirus infection and were associated with the IgM serum fraction in the patients' sera. These reactions were not associated with cytomegalovirus specific IgM, Paul-Bunnell antibody, nor detectable rheumatoid factor. These findings emphasise the need for T gondii dye test confirmation of latex agglutination test titre rises in heart transplant recipients.
Toxoplasma gondii infection is one of the major complications associated with heart transplantation. The most common route of infection is via the donor heart, when a seronegative recipient receives a heart from a seropositive donor.' 2 Reactivation of latent infection has also been shown to take place as a result of the immunosuppressive regimen associated with heart transplantation. 3 In Cambridge Tgondii infections are diagnosed initially by a latex agglutination test4 (Toxoreagent, Eiken Chemical Company) and are confirmed by the dye and haemagglutination tests and an ELISA for specific IgM. Primary T gondii infection is characterised serologically by a rise in latex agglutination, dye and haemagglutination test titres, and the presence of T gondii specific IgM. We noted, however, that in several patients there was a rise in the latex agglutination titre unconfirmed by the other tests. In this study we examine the reasons for this finding.
Material and methods
Betweeen January 1979 and August 1985 123 patients underwent heart and five patients heart and lung transplantations. The first 29 patients received conventional immunosuppression treatment with azathioprine and steroids. The next 82 patients received cyclosporin A and low dose steroids, while Accepted for publication 30 Eight patients seroconverted to T gondii by latex 1137 agglutination (table 2) . Sera from only one of these patients, however, showed evidence of antibody production in the other serological tests, with a rise in the haemagglutination test titre, while the dye test titre remained at < 16. T gondii specific IgM could not be found in sera from any of these patients. In all eight patients seroconversion in the latex agglutination test was noted simultaneously with serological evidence of primary or reactivated cytomegalovirus infection, which occurred between 29 days and four and a half years after transplantation.
By fractioning several of the sera with high nonspecific latex agglutination titres on 15%-40% (w/v) sucrose gradients, it was found that only those frac- 
Discussion
Tgondii is an important cause of morbidity and mortality in heart transplant recipients. While reactivation of latent infection is usually associated with relatively mild symptoms (Wreghitt TG, et al, unpublished observations) death may result, particularly in association with other organisms such as Pneumocystis carinii, cytomegalovirus, and aspergillus.3 Primary infection with Tgondii, which is most often associated with transmission via the donor organ,1 2 9 10 is almost always fatal, unless treated promptly with anti-T gondii chemotherapy. 1 2 10 Primary T gondii infections, like cytomegalovirus infections, become clinically apparent in the first six weeks after transplantation. 1 2 9 10 Starting appropriate treatment depends on prompt diagnosis of infection. Seroconversion to Tgondiican be detected 12- The non-specific latex agglutination seroconversion was associated with cytomegalovirus infection (table  2) , with most patients experiencing cytomegalovirus infection in the first two months after transplantation. One patient (case 1 1), however, did not acquire cytomegalovirus infection until four years after transplantation; this was also associated with non-specific latex agglutination seroconversion. All sera taken from this patient before the onset of the cytomegalovirus infection had a latex agglutination titre < 16. Non-specific latex agglutination titres were associated with primary cytomegalovirus infections (cases 8, 9, 11, 12, and 13) and cytomegalovirus reactivations (cases 7, 10, and 14). Although all the false positive latex agglutination titres were found with sera taken at the time of acute cytomegalovirus infection, sera from many heart transplant recipients experiencing cytomegalovirus infection did not give non-specific latex agglutination titres.
Our inability to identify the serum component producing the non-specific latex agglutination was disappointing, although we an indirect ELISA for the detection of Tgondii IgM in sera from cardiac transplant patients and found non-specific reactions with this assay in sera taken early in the course of transplantation. They showed that this non-specific reaction was caused by the interaction of antibodies directed against the species of origin of ATG (rabbit) used as part of the immunosuppressive regimen and rabbit antibody used as a reagent in their assay. The patients in our series were given horse ATG. Furthermore, one of our patients Serological diagnosis of T gondii infections tested at regular intervals after transplantation acquired primary cytomegalovirus and showed concurrent non-specific latex agglutination titres four and a half years after transplantation and had received ATG only for a short time immediately after transplantation. It is unlikely, therefore, that this false positive reaction was related to ATG antibodies similar to those described in American patients,' 12 and it would seem much more likely that it is associated in some way with active cytomegalovirus infection.
Now that we are aware of the non-specific latex agglutination titres in association with acute cytomegalovirus infection in heart transplant recipients, the chance of an initial erroneous serological diagnosis of T gondii infection is minimised, and we are continuing to use the Eiken latex test and find it a useful screening test. It is, nevertheless, of paramount importance to have a sensitive test (such as p-capture ELISA) for the rapid diagnosis of cytomegalovirus infection and to carry out further confirmatory Tgondii serological tests.
